Antagonizing such elevated CCK/CCKAR signaling in the ASM blocks obesity-induced AHR and thus presents a completely new way to treat asthma in patients with obesity (Fig. 4g). Here, CCKAR is linked to obesity due to melanocortin 4 receptor deficiency.